{"id":1885,"date":"2026-05-08T07:10:32","date_gmt":"2026-05-07T21:10:32","guid":{"rendered":"https:\/\/www.kailomedical.com\/?p=1885"},"modified":"2026-05-09T00:26:48","modified_gmt":"2026-05-08T14:26:48","slug":"fewer-biopsies-better-accuracy-how-ai-is-reshaping-ti-rads-and-bi-rads-reporting","status":"publish","type":"post","link":"https:\/\/www.kailomedical.com\/en-us\/articles\/fewer-biopsies-better-accuracy-how-ai-is-reshaping-ti-rads-and-bi-rads-reporting\/","title":{"rendered":"Fewer Biopsies, Better Accuracy: How AI Is Reshaping TI-RADS and BI-RADS Reporting"},"content":{"rendered":"
\n \n\n
\n

Inside the convergence of structured frameworks and artificial intelligence, and what it means for radiology workflow, consistency, and the data powering what comes next.<\/p>\n

When the ACR published BI-RADS in 1992, the goal was straightforward: give radiologists a shared language for breast imaging findings. TI-RADS followed with the same logic for thyroid nodules; a points-based system to replace subjective assessments with structured, reproducible classifications.<\/p>\n

These frameworks worked. They standardized communication, reduced ambiguity, and gave clinical teams a common basis for management decisions. But they were designed for human application: examine an image, identify features, assign a score, document a recommendation. The framework was, in essence, a checklist.<\/p>\n

That is changing. With 873 FDA-cleared radiology AI algorithms as of mid-2025, artificial intelligence is converging with RADS frameworks in ways that go beyond automation. The question is no longer whether AI belongs in the imaging workflow. It is whether the reporting infrastructure is ready for it.<\/p>\n<\/div> <\/div>\n \n \n <\/div>\n\n\n

\n

\n What AI and Structured Reporting Solve Together <\/h2>\n \n\n
\n

Even with established frameworks, human readers apply criteria inconsistently. Variability in assigning sonographic features, particularly margin characteristics and echogenicity, leads to different TI-RADS classifications for the same nodule depending on who reads it. BI-RADS density assessment introduces similar variability. The lexicon is sound. The application is variable.<\/p>\n

AI changes the equation by sharpening the RADS frameworks at every stage of the reporting workflow.<\/p>\n

Reducing unnecessary biopsies.<\/strong> Before structured risk stratification, fine-needle aspiration rates for detected thyroid nodules were reported as high as 61.9%. ACR TI-RADS reduced unnecessary biopsies by 19.9 to 46.5% compared to other systems. But layer AI on top and the gains compound: one study found that AI-assisted TI-RADS classification cut unnecessary fine-needle aspiration rates from 47.8% to 41.0% while simultaneously improving the missed cancer rate. Fewer procedures, better outcomes.<\/p>\n

Improving diagnostic consistency.<\/strong> A 2024 study in Thyroid<\/em> found that AI decision support improved diagnostic accuracy across readers with varying levels of experience. Deep learning models have achieved over 89% accuracy in automated BI-RADS density classification. The frameworks give AI the structured architecture it needs; AI gives the frameworks the consistency they have always sought.<\/p>\n

Reclaiming clinical time.<\/strong> A 2025 study in JAMA Network Open<\/em>, conducted across 11 hospitals, found that AI-assisted structured reporting improved average documentation efficiency by 15.5%, with some radiologists achieving gains as high as 40%, without compromising accuracy or quality. At a time when 43% of radiologists report spending more time on admin than patient care, that gain is not incremental. It is directional.<\/p>\n<\/div> <\/div>\n \n \n <\/div>\n\n\n\n

\n